Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Enzenhofer, E; Kadletz, L; Stanisz, I; Kotowski, U; Seemann, R; Schmid, R; Thurnher, D; Heiduschka, G.
Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines.
Head Neck. 2017; 39(5):900-907 Doi: 10.1002/hed.24699
Web of Science PubMed FullText FullText_MUG

Co-authors Med Uni Graz: Thurnher Dietmar
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: Carcinogenesis is determined by various epigenetic events, such as histone deacetylation. The purpose of this study was to investigate the effect of the new histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma (HNSCC) cell lines. The cytotoxicity of resminostat and cisplatin on HNSCC cell lines SCC25, CAL27, and FaDu was determined using CCK-8 cell proliferation assay and combination index analysis. Cells were irradiated with 2 to 8 Gray. Apoptosis was measured using flow cytometry and expression of Mcl-1, p-AKT, and survivin was investigated. Treatment with resminostat showed a decrease of cell proliferation of HNSCC cell lines. In addition, a synergistic effect with cisplatin as well as with radiation treatment could be observed. Induction of cell death and dose-dependent downregulation of survivin was evident in all cell lines. Resminostat is a promising treatment of HNSCC because of its antiproliferative, chemosensitizing, and radiosensitizing effects. © 2017 Wiley Periodicals, Inc. Head Neck 39: 900-907, 2017. © 2017 Wiley Periodicals, Inc.
Find related publications in this database (using NLM MeSH Indexing): Antineoplastic Agents - pharmacology; Apoptosis - drug effects; Carcinoma, Squamous Cell - pathology; Cell Line, Tumor -; Cell Proliferation - drug effects; Cell Survival - drug effects; Cisplatin - pharmacology; Head and Neck Neoplasms - pathology; Histone Deacetylase Inhibitors - pharmacology; Humans -; Hydroxamic Acids - pharmacology; Squamous Cell Carcinoma of Head and Neck -; Sulfonamides - pharmacology
Find related publications in this database (Keywords): histone deacetylases; inhibitors; head and neck squamous cell carcinoma; survivin; radiosensitizer; chemosensitizer